<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03496298</url>
  </required_header>
  <id_info>
    <org_study_id>EFC14828</org_study_id>
    <secondary_id>2017-002954-35</secondary_id>
    <secondary_id>U1111-1186-2533</secondary_id>
    <nct_id>NCT03496298</nct_id>
  </id_info>
  <brief_title>Effect of Efpeglenatide on Cardiovascular Outcomes</brief_title>
  <acronym>AMPLITUDE-O</acronym>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hanmi Pharmaceutical Company Limited</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Objective:&#xD;
&#xD;
      To demonstrate that efpeglenatide 4 and 6 mg was noninferior to placebo on 3-point major&#xD;
      adverse cardiac events (MACE) in Type 2 diabetes mellitus (T2DM) participants at high&#xD;
      cardiovascular (CV) risk.&#xD;
&#xD;
      Secondary Objectives:&#xD;
&#xD;
      To demonstrate that efpeglenatide 4 and 6 mg was superior to placebo in T2DM participants&#xD;
      with high CV risk on the following parameters:&#xD;
&#xD;
        -  3-point MACE.&#xD;
&#xD;
        -  Expanded CV outcome.&#xD;
&#xD;
        -  Composite outcome of new or worsening nephropathy.&#xD;
&#xD;
      To assess the safety and tolerability of efpeglenatide 4 and 6 mg, both added to standard of&#xD;
      care in T2DM participants at high CV risk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study duration per participant was up to approximately 36 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor decision to cancel TRIAL, not related to safety concern&#xD;
  </why_stopped>
  <start_date type="Actual">April 27, 2018</start_date>
  <completion_date type="Actual">December 10, 2020</completion_date>
  <primary_completion_date type="Actual">December 10, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to First Occurrence of Major Adverse Cardiovascular Events (MACE): Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular (CV) Event - Non-Inferiority Analysis</measure>
    <time_frame>From Day 1 until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 31.5 months)</time_frame>
    <description>All MACE positively adjudicated by the clinical endpoint committee (CEC) were used in the analysis of the composite outcome of first occurrence to CV death, non-fatal myocardial infarction (MI), and non-fatal stroke. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First Occurrence of Major Adverse Cardiovascular Events: Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular Event - Superiority Analysis</measure>
    <time_frame>From Day 1 until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 31.5 months)</time_frame>
    <description>All MACE positively adjudicated by the CEC were used in the analysis of the composite outcome of first occurrence to CV death, non-fatal MI, and non-fatal stroke. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Occurrence of the Expanded Major Adverse Cardiovascular Events Composite Events: Event Rate Per 100 Participant-years for First Occurrence of Expanded Major Cardiovascular Event</measure>
    <time_frame>From Day 1 until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 31.5 months)</time_frame>
    <description>All MACE positively adjudicated by the CEC were used in the analysis of the expanded outcome of first occurrence to CV death (including fatal MI and fatal stroke), non-fatal MI, non-fatal stroke, coronary revascularization or hospitalization for unstable angina. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported. Data analysis was also performed independently by external steering committee for the publication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Occurrence of Composite Renal Endpoint: Event Rate Per 100 Participant-years for First Occurrence of Composite Renal Endpoint</measure>
    <time_frame>From Day 1 until the confirmed occurrence of composite renal endpoint (maximum duration: up to 31.5 months)</time_frame>
    <description>Composite renal endpoint included the following: incident macroalbuminuria (defined as urinary albumin-to-creatinine ratio of greater than (&gt;) 300, as measured in mg of albumin to grams of creatinine, or &gt;33.9, as measured in mg of albumin to millimoles of creatinine), plus an increase in urinary albumin-to-creatinine ratio of at least 30% from baseline, a sustained decrease in estimated glomerular filtration rate (eGFR) of at least 40% for 30 days or more, renal-replacement therapy for 90 days or more, and a sustained eGFR of less than 15 ml per minute per 1.73 m^2 for 30 days or more. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of renal endpoint over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">4076</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants received placebo (matched to Efpeglenatide) as subcutaneous (SC) injection once weekly up to end of treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Efpeglenatide 4 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received Efpeglenatide as SC injection 2 milligrams (mg) per week for 4 weeks then 4 mg per week up to end of treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Efpeglenatide 6 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks, then 4 mg per week for 4 weeks and then 6 mg per week up to end of treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Efpeglenatide (SAR439977)</intervention_name>
    <description>Pharmaceutical form: Solution for injection,&#xD;
Route of administration: SC</description>
    <arm_group_label>Efpeglenatide 4 mg</arm_group_label>
    <arm_group_label>Efpeglenatide 6 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Pharmaceutical form: Solution for injection&#xD;
Route of administration: SC</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  T2DM with glycosylated hemoglobin (HbA1c) greater than (&gt;) 7 percentage.&#xD;
&#xD;
          -  Age 18 years or older who met at least one of the cardiovascular disease criteria or&#xD;
             age 50 years (male), 55 years (female) or older with glomerular filtration rate&#xD;
             greater than or equal to 25 and less than 60 milliliters per minute and at least had&#xD;
             one cardiovascular risk factor.&#xD;
&#xD;
          -  Female participants agreed to follow contraceptive guidance.&#xD;
&#xD;
          -  Signed written informed consent.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Clinically relevant history of gastrointestinal disease associated with prolonged&#xD;
             nausea and vomiting.&#xD;
&#xD;
          -  History of chronic pancreatitis or acute idiopathic pancreatitis or diagnosis of any&#xD;
             type of acute pancreatitis within 3 months prior to screening.&#xD;
&#xD;
          -  Personal or family history of medullary thyroid cancer.&#xD;
&#xD;
          -  Hypertension (with a systolic blood pressure &gt;180 millimeters of Mercury [mmHg] and/or&#xD;
             diastolic blood pressure &gt;100 mmHg).&#xD;
&#xD;
          -  Hospitalization for hypertensive emergency within 3 months prior to randomization.&#xD;
&#xD;
          -  Planned coronary procedure or surgery after randomization.&#xD;
&#xD;
          -  No documented ophthalmologic exam with fundoscopy within 6 months prior to&#xD;
             randomization.&#xD;
&#xD;
          -  Retinopathy or maculopathy with treatment, either recent (3 months prior to&#xD;
             randomization) or planned during the study.&#xD;
&#xD;
          -  Treated with any glucagon-like peptide-1 receptor agonist product alone (eg,&#xD;
             exenatide, liraglutide, lixisenatide, albiglutide, dulaglutide, semaglutide) or in&#xD;
             combination within 3 months prior to screening.&#xD;
&#xD;
          -  Use of any Dipeptidyl peptidase 4 inhibitor within 3 months prior to screening.&#xD;
&#xD;
          -  Antihyperglycemic treatment had not been stable within 3 months prior to screening.&#xD;
&#xD;
        The above information was not intended to contain all considerations relevant to a&#xD;
        participant's potential participation in a clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Sciences &amp; Operations</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Investigational Site Number 8400032</name>
      <address>
        <city>Sheffield</city>
        <state>Alabama</state>
        <zip>35660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400014</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400012</name>
      <address>
        <city>Surprise</city>
        <state>Arizona</state>
        <zip>85374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400046</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400022</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400065</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400060</name>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <zip>94904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400084</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400002</name>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <zip>95032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400085</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400082</name>
      <address>
        <city>Pomona</city>
        <state>California</state>
        <zip>91767</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400025</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95821</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400064</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400019</name>
      <address>
        <city>Hamden</city>
        <state>Connecticut</state>
        <zip>06517</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400023</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <zip>06708-3346</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400091</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400040</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400073</name>
      <address>
        <city>Hudson</city>
        <state>Florida</state>
        <zip>34667</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400011</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400017</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400042</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32277</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400027</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400051</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400041</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <zip>34652</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400059</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400006</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31210-1359</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400008</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400081</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400095</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400070</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400036</name>
      <address>
        <city>Crystal Lake</city>
        <state>Illinois</state>
        <zip>60012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400030</name>
      <address>
        <city>New Albany</city>
        <state>Indiana</state>
        <zip>46113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400074</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400077</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400043</name>
      <address>
        <city>Paris</city>
        <state>Kentucky</state>
        <zip>40361</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400034</name>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <zip>71301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400079</name>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <zip>71203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400013</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400047</name>
      <address>
        <city>Oxon Hill</city>
        <state>Maryland</state>
        <zip>20745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400001</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400061</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532-3447</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400010</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400005</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400024</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400045</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400071</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400028</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405-4507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400086</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400037</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400087</name>
      <address>
        <city>Raritan</city>
        <state>New Jersey</state>
        <zip>08869</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400018</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400056</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400076</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834-5704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400007</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400093</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400094</name>
      <address>
        <city>Morganton</city>
        <state>North Carolina</state>
        <zip>28655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400029</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400031</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400078</name>
      <address>
        <city>Lorain</city>
        <state>Ohio</state>
        <zip>44053</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400072</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400067</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <zip>15009-1957</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400096</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400021</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400015</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400063</name>
      <address>
        <city>Murrells Inlet</city>
        <state>South Carolina</state>
        <zip>29576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400044</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400016</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400009</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400055</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400097</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400088</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79935</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400058</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400069</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400089</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400092</name>
      <address>
        <city>Richmond</city>
        <state>Texas</state>
        <zip>77469</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400033</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400039</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400052</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8400049</name>
      <address>
        <city>Manitowoc</city>
        <state>Wisconsin</state>
        <zip>54220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320009</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1430</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320002</name>
      <address>
        <city>Caba</city>
        <zip>1120</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320013</name>
      <address>
        <city>Caba</city>
        <zip>1425DES</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320010</name>
      <address>
        <city>Caba</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320005</name>
      <address>
        <city>Caba</city>
        <zip>C1119ACN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320008</name>
      <address>
        <city>Capital Federal</city>
        <zip>C1056ABJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320001</name>
      <address>
        <city>Capital Federal</city>
        <zip>C1179AAB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320004</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400AMZ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320012</name>
      <address>
        <city>Corrientes</city>
        <zip>W3410AVV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320011</name>
      <address>
        <city>Godoy Cruz</city>
        <zip>M5501ARP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320007</name>
      <address>
        <city>Mar Del Plata</city>
        <zip>B7600FZN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320006</name>
      <address>
        <city>Merlo</city>
        <zip>B1722COV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320015</name>
      <address>
        <city>Rosario</city>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320017</name>
      <address>
        <city>Rosario</city>
        <zip>S2002OJP</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320003</name>
      <address>
        <city>Salta</city>
        <zip>4400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320018</name>
      <address>
        <city>Salta</city>
        <zip>4400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320016</name>
      <address>
        <city>San Isidro</city>
        <zip>B1642DCB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 0320014</name>
      <address>
        <city>Santa Rosa</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000011</name>
      <address>
        <city>Blagoevgrad</city>
        <zip>2700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000014</name>
      <address>
        <city>Dimitrovgrad</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000017</name>
      <address>
        <city>Gabrovo</city>
        <zip>5300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000007</name>
      <address>
        <city>Kazanlak</city>
        <zip>6100</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000013</name>
      <address>
        <city>Kyustendil</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000010</name>
      <address>
        <city>Lovech</city>
        <zip>5500</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000008</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000002</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000012</name>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000003</name>
      <address>
        <city>Sofia</city>
        <zip>1233</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000001</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000005</name>
      <address>
        <city>Sofia</city>
        <zip>1750</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000006</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000009</name>
      <address>
        <city>Varna</city>
        <zip>9000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1000016</name>
      <address>
        <city>Yambol</city>
        <zip>8600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240001</name>
      <address>
        <city>Barrie</city>
        <zip>L4N 7L3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240002</name>
      <address>
        <city>Brampton</city>
        <zip>L6S 0C6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240018</name>
      <address>
        <city>Burlington</city>
        <zip>L7M 1K9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240021</name>
      <address>
        <city>Burlington</city>
        <zip>L7R 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240007</name>
      <address>
        <city>Calgary</city>
        <zip>T2H 2G4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240020</name>
      <address>
        <city>Calgary</city>
        <zip>T2V 4J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240024</name>
      <address>
        <city>Chicoutimi</city>
        <zip>G7H 7K9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240004</name>
      <address>
        <city>Concord</city>
        <zip>L4K 4M2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240005</name>
      <address>
        <city>Etobicoke</city>
        <zip>M9R 4E1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240011</name>
      <address>
        <city>Levis</city>
        <zip>G6W 0M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240025</name>
      <address>
        <city>London</city>
        <zip>N5W 6A2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240028</name>
      <address>
        <city>London</city>
        <zip>N6A 5R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240029</name>
      <address>
        <city>Mirabel</city>
        <zip>J7J 2K8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240008</name>
      <address>
        <city>Montreal</city>
        <zip>H1M 1B1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240031</name>
      <address>
        <city>Montreal</city>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240014</name>
      <address>
        <city>Montreal</city>
        <zip>H4A 2C6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240023</name>
      <address>
        <city>Montreal</city>
        <zip>H4A 3T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240017</name>
      <address>
        <city>Montreal</city>
        <zip>H4N 2W2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240015</name>
      <address>
        <city>Oakville</city>
        <zip>L6M 1M1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240012</name>
      <address>
        <city>Oshawa</city>
        <zip>L1J 2K1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240030</name>
      <address>
        <city>Ottawa</city>
        <zip>K2J 0V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240027</name>
      <address>
        <city>Peterborough</city>
        <zip>K9J 0B2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240016</name>
      <address>
        <city>Pointe-Claire</city>
        <zip>H9R 4S3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240010</name>
      <address>
        <city>Quebec</city>
        <zip>G1N 4V3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240019</name>
      <address>
        <city>Red Deer</city>
        <zip>T4N 6V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240006</name>
      <address>
        <city>Sherbrooke</city>
        <zip>J1L 0H8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240022</name>
      <address>
        <city>Sudbury</city>
        <zip>P3E 4H5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240013</name>
      <address>
        <city>Toronto</city>
        <zip>M4G 3E8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240003</name>
      <address>
        <city>Vancouver</city>
        <zip>V5Y 3W2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240009</name>
      <address>
        <city>Victoriaville</city>
        <zip>G6P 6P6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1240026</name>
      <address>
        <city>Victoria</city>
        <zip>V8V 4A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520012</name>
      <address>
        <city>Antofagasta</city>
        <zip>1270013</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520008</name>
      <address>
        <city>Concepcin</city>
        <zip>4070566</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520013</name>
      <address>
        <city>Santiago</city>
        <zip>7500571</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520002</name>
      <address>
        <city>Santiago</city>
        <zip>7500710</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520007</name>
      <address>
        <city>Santiago</city>
        <zip>7500710</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520011</name>
      <address>
        <city>Santiago</city>
        <zip>7770086</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520010</name>
      <address>
        <city>Santiago</city>
        <zip>8053095</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520001</name>
      <address>
        <city>Santiago</city>
        <zip>8330336</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520003</name>
      <address>
        <city>Santiago</city>
        <zip>8380456</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520014</name>
      <address>
        <city>Santiago</city>
        <zip>8900132</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520005</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520006</name>
      <address>
        <city>Temuco</city>
        <zip>4813299</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 1520004</name>
      <address>
        <city>Via Del Mar</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2080004</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2080005</name>
      <address>
        <city>Esbjerg</city>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2080001</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2080003</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2080002</name>
      <address>
        <city>Kbenhavn Nv</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2330002</name>
      <address>
        <city>Prnu</city>
        <zip>80018</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2330001</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2330003</name>
      <address>
        <city>Viljandi</city>
        <zip>71024</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2460002</name>
      <address>
        <city>Helsinki</city>
        <zip>00100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2460001</name>
      <address>
        <city>Jyvskyl</city>
        <zip>40620</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2460003</name>
      <address>
        <city>Kuopio</city>
        <zip>70100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2460004</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760006</name>
      <address>
        <city>Berlin</city>
        <zip>10437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760009</name>
      <address>
        <city>Berlin</city>
        <zip>12627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760004</name>
      <address>
        <city>Essen</city>
        <zip>45355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760008</name>
      <address>
        <city>Frankfurt Am Main</city>
        <zip>60313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760005</name>
      <address>
        <city>Mnster</city>
        <zip>48145</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760003</name>
      <address>
        <city>Oldenburg In Holstein</city>
        <zip>23758</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760002</name>
      <address>
        <city>Pirna</city>
        <zip>01796</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 2760007</name>
      <address>
        <city>Rotenburg An Der Fulda</city>
        <zip>36199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480012</name>
      <address>
        <city>Balatonfred</city>
        <zip>8230</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480011</name>
      <address>
        <city>Budapest</city>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480003</name>
      <address>
        <city>Budapest</city>
        <zip>1042</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480005</name>
      <address>
        <city>Budapest</city>
        <zip>1106</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480001</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480006</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480002</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480009</name>
      <address>
        <city>Komrom</city>
        <zip>2900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480008</name>
      <address>
        <city>Mosonmagyarvr</city>
        <zip>9200</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480007</name>
      <address>
        <city>Szkesfehrvr</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3480004</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560001</name>
      <address>
        <city>Belgaum</city>
        <zip>590010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560002</name>
      <address>
        <city>Gurgaon</city>
        <zip>122001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560007</name>
      <address>
        <city>Kolkata</city>
        <zip>700073</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560006</name>
      <address>
        <city>Lucknow</city>
        <zip>226002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560003</name>
      <address>
        <city>New Delhi</city>
        <zip>110 029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560009</name>
      <address>
        <city>New Delhi</city>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560010</name>
      <address>
        <city>Pune</city>
        <zip>411001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560005</name>
      <address>
        <city>Pune</city>
        <zip>411010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3560004</name>
      <address>
        <city>Vellore</city>
        <zip>632004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3800006</name>
      <address>
        <city>Catania</city>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3800003</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3800005</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3800002</name>
      <address>
        <city>Chieti</city>
        <zip>66013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3800001</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 3800004</name>
      <address>
        <city>Roma</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100006</name>
      <address>
        <city>Guri-si</city>
        <state>Gyeonggi-Do</state>
        <zip>11923</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100007</name>
      <address>
        <city>Busan</city>
        <zip>49241</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100005</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100002</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100009</name>
      <address>
        <city>Seoul</city>
        <zip>03181</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100001</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100011</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100003</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100010</name>
      <address>
        <city>Seoul</city>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4100008</name>
      <address>
        <city>Wonju</city>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4280004</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV-5417</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4280002</name>
      <address>
        <city>Liepja</city>
        <zip>LV3414</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4280001</name>
      <address>
        <city>Riga</city>
        <zip>LV-1011</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4280003</name>
      <address>
        <city>Sigulda</city>
        <zip>LV-2150</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4400001</name>
      <address>
        <city>Kaunas</city>
        <zip>49449</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4400002</name>
      <address>
        <city>Kaunas</city>
        <zip>50161</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4400003</name>
      <address>
        <city>Klaipeda</city>
        <zip>92111</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4400004</name>
      <address>
        <city>Vilnius</city>
        <zip>08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840004</name>
      <address>
        <city>Actopan</city>
        <zip>42500</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840007</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840009</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840013</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840014</name>
      <address>
        <city>Chihuahua</city>
        <zip>31000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840002</name>
      <address>
        <city>Cuernavaca</city>
        <zip>62250</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840016</name>
      <address>
        <city>Durango</city>
        <zip>34000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840015</name>
      <address>
        <city>Durango</city>
        <zip>34080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840006</name>
      <address>
        <city>Guadalajara</city>
        <zip>44210</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840003</name>
      <address>
        <city>Guadalajara</city>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840005</name>
      <address>
        <city>Guadalajara</city>
        <zip>44650</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840011</name>
      <address>
        <city>Monterrey</city>
        <zip>64020</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840010</name>
      <address>
        <city>Monterrey</city>
        <zip>64060</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 4840001</name>
      <address>
        <city>Monterrey</city>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 5780002</name>
      <address>
        <city>Hamar</city>
        <zip>2317</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 5780001</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 5780003</name>
      <address>
        <city>Stavanger</city>
        <zip>4011</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040007</name>
      <address>
        <city>Lima</city>
        <zip>LIMA 01</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040004</name>
      <address>
        <city>Lima</city>
        <zip>LIMA 11</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040003</name>
      <address>
        <city>Lima</city>
        <zip>LIMA 27</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040006</name>
      <address>
        <city>Lima</city>
        <zip>LIMA 31</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040001</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040005</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6040002</name>
      <address>
        <city>Piura</city>
        <zip>20000</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160017</name>
      <address>
        <city>Bialystok</city>
        <zip>15-404</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160018</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>80-095</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160015</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-090</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160016</name>
      <address>
        <city>Gdansk</city>
        <zip>80-546</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160012</name>
      <address>
        <city>Gdansk</city>
        <zip>80-858</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160005</name>
      <address>
        <city>Katowice</city>
        <zip>40-530</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160006</name>
      <address>
        <city>Plock</city>
        <zip>09-402</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160011</name>
      <address>
        <city>Skierniewice</city>
        <zip>96-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160013</name>
      <address>
        <city>Skorzewo</city>
        <zip>60-185</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160010</name>
      <address>
        <city>Szczecin</city>
        <zip>70-506</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160007</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160009</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160014</name>
      <address>
        <city>Tychy</city>
        <zip>43-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160002</name>
      <address>
        <city>Warszawa</city>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6160004</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-315</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420007</name>
      <address>
        <city>Bacau</city>
        <zip>600154</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420001</name>
      <address>
        <city>Brasov</city>
        <zip>500097</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420011</name>
      <address>
        <city>Brasov</city>
        <zip>500365</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420009</name>
      <address>
        <city>Bucuresti</city>
        <zip>020475</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420012</name>
      <address>
        <city>Oradea</city>
        <zip>410151</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420005</name>
      <address>
        <city>Oradea</city>
        <zip>410159</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420010</name>
      <address>
        <city>Oradea</city>
        <zip>410169</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420008</name>
      <address>
        <city>Ploiesti</city>
        <zip>100561</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420002</name>
      <address>
        <city>Trgu-Mure</city>
        <zip>540142</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6420003</name>
      <address>
        <city>Trgu-Mure</city>
        <zip>540142</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430018</name>
      <address>
        <city>Kaliningrad</city>
        <zip>236035</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430014</name>
      <address>
        <city>Kazan</city>
        <zip>420087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430001</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430017</name>
      <address>
        <city>Krasnogorsk</city>
        <zip>143408</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430004</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430005</name>
      <address>
        <city>Moscow</city>
        <zip>117292</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430002</name>
      <address>
        <city>Moscow</city>
        <zip>121374</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430015</name>
      <address>
        <city>Moscow</city>
        <zip>121552</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430009</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430019</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430006</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>190013</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430012</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>198205</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430003</name>
      <address>
        <city>Saratov</city>
        <zip>410028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430020</name>
      <address>
        <city>Saratov</city>
        <zip>410039</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430010</name>
      <address>
        <city>St-Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430011</name>
      <address>
        <city>St-Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430013</name>
      <address>
        <city>St. Petersburg</city>
        <zip>194156</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6430016</name>
      <address>
        <city>St. Petersburg</city>
        <zip>195067</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6880001</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6880002</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6880003</name>
      <address>
        <city>Belgrade</city>
        <zip>11050</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6880005</name>
      <address>
        <city>Belgrade</city>
        <zip>11050</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6880004</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 6880006</name>
      <address>
        <city>Novi Sad</city>
        <zip>21000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030007</name>
      <address>
        <city>Bratislava</city>
        <zip>85101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030001</name>
      <address>
        <city>Kosice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030004</name>
      <address>
        <city>Kosice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030003</name>
      <address>
        <city>Kralovsky Chlmec</city>
        <zip>077 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030009</name>
      <address>
        <city>Moldava Nad Bodvou</city>
        <zip>04525</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030010</name>
      <address>
        <city>Pezinok</city>
        <zip>90201</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030006</name>
      <address>
        <city>Povazska Bystrica</city>
        <zip>01701</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030005</name>
      <address>
        <city>Presov</city>
        <zip>080 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030008</name>
      <address>
        <city>Roznava</city>
        <zip>04801</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030011</name>
      <address>
        <city>Sturovo</city>
        <zip>943 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030002</name>
      <address>
        <city>Trebisov</city>
        <zip>075 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7030012</name>
      <address>
        <city>Trencin</city>
        <zip>91101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100007</name>
      <address>
        <city>Bloemfontein</city>
        <zip>9301</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100005</name>
      <address>
        <city>Cape Town</city>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100006</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100003</name>
      <address>
        <city>Johannesburg</city>
        <zip>1752</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100001</name>
      <address>
        <city>Johannesburg</city>
        <zip>2198</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100002</name>
      <address>
        <city>Parow</city>
        <zip>7500</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100004</name>
      <address>
        <city>Rivonia</city>
        <zip>2128</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7100008</name>
      <address>
        <city>Umhlanga Rocks Suburb</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240008</name>
      <address>
        <city>Alcorcn</city>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240002</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240009</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240007</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240010</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240001</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240006</name>
      <address>
        <city>Majadahonda</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240011</name>
      <address>
        <city>Mlaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240005</name>
      <address>
        <city>Olot</city>
        <zip>17800</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240003</name>
      <address>
        <city>San Sebastin De Los Reyes</city>
        <zip>28702</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240013</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240004</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7240014</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7520006</name>
      <address>
        <city>Goteborg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7520003</name>
      <address>
        <city>Helsingborg</city>
        <zip>252 20</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7520004</name>
      <address>
        <city>Kristianstad</city>
        <zip>291 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7520002</name>
      <address>
        <city>Malm</city>
        <zip>211 52</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7520005</name>
      <address>
        <city>Skvde</city>
        <zip>541 40</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7520001</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920005</name>
      <address>
        <city>Adana</city>
        <zip>01250</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920010</name>
      <address>
        <city>Ankara</city>
        <zip>06490</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920012</name>
      <address>
        <city>Antalya</city>
        <zip>07070</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920015</name>
      <address>
        <city>Aydin</city>
        <zip>09100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920002</name>
      <address>
        <city>Bursa</city>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920013</name>
      <address>
        <city>Eskisehir</city>
        <zip>26040</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920001</name>
      <address>
        <city>Istanbul</city>
        <zip>34393</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920006</name>
      <address>
        <city>Istanbul</city>
        <zip>34843</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920011</name>
      <address>
        <city>Izmit</city>
        <zip>41380</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920014</name>
      <address>
        <city>Kutahya</city>
        <zip>43040</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920007</name>
      <address>
        <city>Samsun</city>
        <zip>55139</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 7920009</name>
      <address>
        <city>Sivas</city>
        <zip>58140</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040006</name>
      <address>
        <city>Dnipro</city>
        <zip>49005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040009</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76008</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040001</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040003</name>
      <address>
        <city>Kharkiv</city>
        <zip>61124</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040002</name>
      <address>
        <city>Kharkiv</city>
        <zip>61166</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040007</name>
      <address>
        <city>Kiev</city>
        <zip>02091</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040008</name>
      <address>
        <city>Kyiv</city>
        <zip>01004</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040004</name>
      <address>
        <city>Ternopil</city>
        <zip>46000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site Number 8040005</name>
      <address>
        <city>Vinnytsya</city>
        <zip>21001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Denmark</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28.</citation>
    <PMID>34215025</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 5, 2018</study_first_submitted>
  <study_first_submitted_qc>April 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <results_first_submitted>September 16, 2021</results_first_submitted>
  <results_first_submitted_qc>September 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 15, 2021</results_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Efpeglenatide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share individual participant data (IPD) by Sanofi: product rights transferred to Hanmi pharmaceutical.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 30, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/98/NCT03496298/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 12, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/98/NCT03496298/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted at 344 active sites in 28 countries. Overall, 5732 participants were screened between 27 April 2018 and 25 April 2019; of whom 4076 participants were randomized by interactive response technology (1:1:1 ratio) to receive placebo, efpeglenatide 4 milligrams (mg) or efpeglenatide 6 mg. Screen failures were mainly due to inclusion criteria not met.</recruitment_details>
      <pre_assignment_details>Randomization was stratified by the current or potential future use of a sodium-glucose co-transporter-2 (SGLT2) inhibitor: current use; potential future use; neither current nor potential future use.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Participants received placebo (matched to Efpeglenatide) as subcutaneous (SC) injection once weekly up to end of treatment (median duration: 19.8 months).</description>
        </group>
        <group group_id="P2">
          <title>Efpeglenatide 4 mg</title>
          <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks then 4 mg per week up to end of treatment (median duration: 19.9 months).</description>
        </group>
        <group group_id="P3">
          <title>Efpeglenatide 6 mg</title>
          <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks, then 4 mg per week for 4 weeks and then 6 mg per week up to end of treatment (median duration: 20 months).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1359"/>
                <participants group_id="P2" count="1359"/>
                <participants group_id="P3" count="1358"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Randomized and Treated</title>
              <participants_list>
                <participants group_id="P1" count="1358"/>
                <participants group_id="P2" count="1358"/>
                <participants group_id="P3" count="1357"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Population</title>
              <participants_list>
                <participants group_id="P1" count="1355">2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.</participants>
                <participants group_id="P2" count="1360">2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.</participants>
                <participants group_id="P3" count="1358">1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1317"/>
                <participants group_id="P2" count="1323"/>
                <participants group_id="P3" count="1335"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="68"/>
                <participants group_id="P3" count="79"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study terminated by Sponsor</title>
              <participants_list>
                <participants group_id="P1" count="1050"/>
                <participants group_id="P2" count="1063"/>
                <participants group_id="P3" count="1071"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician decision (other than Adverse event)</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="176"/>
                <participants group_id="P2" count="154"/>
                <participants group_id="P3" count="151"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Randomized and not treated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analysis was performed on Intent-to-treat (ITT) population that included all randomized participants irrespective of compliance with the study protocol and procedures and were analyzed in the treatment group to which they were randomized.</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Participants received placebo (matched to Efpeglenatide) as SC injection once weekly up to end of treatment (median duration: 19.8 months).</description>
        </group>
        <group group_id="B2">
          <title>Efpeglenatide 4 mg</title>
          <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks then 4 mg per week up to end of treatment (median duration: 19.9 months).</description>
        </group>
        <group group_id="B3">
          <title>Efpeglenatide 6 mg</title>
          <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks, then 4 mg per week for 4 weeks and then 6 mg per week up to end of treatment (median duration: 20 months).</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1359"/>
            <count group_id="B2" value="1359"/>
            <count group_id="B3" value="1358"/>
            <count group_id="B4" value="4076"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1359"/>
                    <count group_id="B2" value="1359"/>
                    <count group_id="B3" value="1358"/>
                    <count group_id="B4" value="4076"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.4" spread="8.3"/>
                    <measurement group_id="B2" value="64.6" spread="8.2"/>
                    <measurement group_id="B3" value="64.7" spread="8.2"/>
                    <measurement group_id="B4" value="64.5" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1359"/>
                    <count group_id="B2" value="1359"/>
                    <count group_id="B3" value="1358"/>
                    <count group_id="B4" value="4076"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="419"/>
                    <measurement group_id="B2" value="442"/>
                    <measurement group_id="B3" value="483"/>
                    <measurement group_id="B4" value="1344"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="940"/>
                    <measurement group_id="B2" value="917"/>
                    <measurement group_id="B3" value="875"/>
                    <measurement group_id="B4" value="2732"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1359"/>
                    <count group_id="B2" value="1359"/>
                    <count group_id="B3" value="1358"/>
                    <count group_id="B4" value="4076"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="82"/>
                    <measurement group_id="B4" value="267"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="55"/>
                    <measurement group_id="B4" value="143"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1162"/>
                    <measurement group_id="B2" value="1192"/>
                    <measurement group_id="B3" value="1180"/>
                    <measurement group_id="B4" value="3534"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <population>Here, 'number analyzed' = participants with available data for the specified baseline measure.</population>
          <units>kilogram meter per square (kg/m^2)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1359"/>
                    <count group_id="B2" value="1357"/>
                    <count group_id="B3" value="1357"/>
                    <count group_id="B4" value="4073"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.40" spread="6.01"/>
                    <measurement group_id="B2" value="32.81" spread="6.22"/>
                    <measurement group_id="B3" value="32.90" spread="6.21"/>
                    <measurement group_id="B4" value="32.70" spread="6.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to First Occurrence of Major Adverse Cardiovascular Events (MACE): Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular (CV) Event - Non-Inferiority Analysis</title>
        <description>All MACE positively adjudicated by the clinical endpoint committee (CEC) were used in the analysis of the composite outcome of first occurrence to CV death, non-fatal myocardial infarction (MI), and non-fatal stroke. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
        <time_frame>From Day 1 until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 31.5 months)</time_frame>
        <population>Analysis was performed on intent-to-treat (ITT) population. Data for this outcome measure (OM) was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Efpeglenatide 4 mg+6 mg</title>
            <description>Included all participants who received either Efpeglenatide 4 mg or 6 mg as SC injection once weekly up to end of treatment (median duration: 19.9 months).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received placebo (matched to Efpeglenatide) as SC injection once weekly up to end of treatment (median duration: 19.8 months).</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of Major Adverse Cardiovascular Events (MACE): Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular (CV) Event - Non-Inferiority Analysis</title>
          <description>All MACE positively adjudicated by the clinical endpoint committee (CEC) were used in the analysis of the composite outcome of first occurrence to CV death, non-fatal myocardial infarction (MI), and non-fatal stroke. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
          <population>Analysis was performed on intent-to-treat (ITT) population. Data for this outcome measure (OM) was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
          <units>events per 100 participant-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2717"/>
                <count group_id="O2" value="1359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" lower_limit="3.4" upper_limit="4.5"/>
                    <measurement group_id="O2" value="5.3" lower_limit="4.4" upper_limit="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Hazard ratio and 95% Confidence Interval (CI) were obtained from a Cox proportional hazards model with region (North America, Latin America, Europe, other), randomization stratum of SGLT2 inhibitor use (current use, potential future use, neither current nor potential future use) and treatment (efpeglenatide 4 mg, efpeglenatide 6 mg, placebo) as fixed effect factor.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority of efpeglenatide 4 mg+6 mg versus placebo was to be claimed if the upper bound of the 2-sided 95% CI of the hazard ratio for the incidence of both 1.8 and less and 1.3 or less.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>One-sided p-value based on log rank test of hazard ratio for the incidence of both 1.8 and less and 1.3 or less.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.732</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.583</ci_lower_limit>
            <ci_upper_limit>0.918</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Occurrence of Major Adverse Cardiovascular Events: Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular Event - Superiority Analysis</title>
        <description>All MACE positively adjudicated by the CEC were used in the analysis of the composite outcome of first occurrence to CV death, non-fatal MI, and non-fatal stroke. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
        <time_frame>From Day 1 until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 31.5 months)</time_frame>
        <population>Analysis was performed on ITT population. Data for this OM was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Efpeglenatide 4 mg+6 mg</title>
            <description>Included all participants who received either Efpeglenatide 4 mg or 6 mg as SC injection once weekly up to end of treatment (median duration: 19.9 months).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received placebo (matched to Efpeglenatide) as SC injection once weekly up to end of treatment (median duration: 19.8 months).</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of Major Adverse Cardiovascular Events: Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular Event - Superiority Analysis</title>
          <description>All MACE positively adjudicated by the CEC were used in the analysis of the composite outcome of first occurrence to CV death, non-fatal MI, and non-fatal stroke. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
          <population>Analysis was performed on ITT population. Data for this OM was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
          <units>events per 100 participant-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2717"/>
                <count group_id="O2" value="1359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" lower_limit="3.4" upper_limit="4.5"/>
                    <measurement group_id="O2" value="5.3" lower_limit="4.4" upper_limit="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Hazard ratio and 95% CI were obtained from a Cox proportional hazards model with region (North America, Latin America, Europe, other), randomization stratum of SGLT2 inhibitor use (current use, potential future use, neither current nor potential future use) and treatment (efpeglenatide 4 mg, efpeglenatide 6 mg, placebo) as fixed effect factor.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was claimed when the upper bound of the 2-sided 95% CI of hazard ratio was less than 1.</non_inferiority_desc>
            <p_value>0.0069</p_value>
            <p_value_desc>Two-sided p-values based on log rank test of hazard ratio.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.732</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.583</ci_lower_limit>
            <ci_upper_limit>0.918</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Occurrence of the Expanded Major Adverse Cardiovascular Events Composite Events: Event Rate Per 100 Participant-years for First Occurrence of Expanded Major Cardiovascular Event</title>
        <description>All MACE positively adjudicated by the CEC were used in the analysis of the expanded outcome of first occurrence to CV death (including fatal MI and fatal stroke), non-fatal MI, non-fatal stroke, coronary revascularization or hospitalization for unstable angina. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported. Data analysis was also performed independently by external steering committee for the publication.</description>
        <time_frame>From Day 1 until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 31.5 months)</time_frame>
        <population>Analysis was performed on ITT population. Data for this OM was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Efpeglenatide 4 mg+6 mg</title>
            <description>Included all participants who received either Efpeglenatide 4 mg or 6 mg as SC injection once weekly up to end of treatment (median duration: 19.9 months).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received placebo (matched to Efpeglenatide) as SC injection once weekly up to end of treatment (median duration: 19.8 months).</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of the Expanded Major Adverse Cardiovascular Events Composite Events: Event Rate Per 100 Participant-years for First Occurrence of Expanded Major Cardiovascular Event</title>
          <description>All MACE positively adjudicated by the CEC were used in the analysis of the expanded outcome of first occurrence to CV death (including fatal MI and fatal stroke), non-fatal MI, non-fatal stroke, coronary revascularization or hospitalization for unstable angina. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of MACE over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported. Data analysis was also performed independently by external steering committee for the publication.</description>
          <population>Analysis was performed on ITT population. Data for this OM was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
          <units>events per 100 participant-years</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2717"/>
                <count group_id="O2" value="1359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4"/>
                    <measurement group_id="O2" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Hazard ratio and 95% CI were obtained from a Cox proportional hazards model with region (North America, Latin America, Europe, other), randomization stratum of SGLT2 inhibitor use (current use, potential future use, neither current nor potential future use) and treatment (efpeglenatide 4 mg, efpeglenatide 6 mg, placebo) as fixed effect factor.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was claimed when the upper bound of the 2-sided 95% CI of hazard ratio was less than 1.</non_inferiority_desc>
            <p_value>0.02</p_value>
            <p_value_desc>Two-sided p-values based on log rank test of hazard ratio.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.65</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Occurrence of Composite Renal Endpoint: Event Rate Per 100 Participant-years for First Occurrence of Composite Renal Endpoint</title>
        <description>Composite renal endpoint included the following: incident macroalbuminuria (defined as urinary albumin-to-creatinine ratio of greater than (&gt;) 300, as measured in mg of albumin to grams of creatinine, or &gt;33.9, as measured in mg of albumin to millimoles of creatinine), plus an increase in urinary albumin-to-creatinine ratio of at least 30% from baseline, a sustained decrease in estimated glomerular filtration rate (eGFR) of at least 40% for 30 days or more, renal-replacement therapy for 90 days or more, and a sustained eGFR of less than 15 ml per minute per 1.73 m^2 for 30 days or more. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of renal endpoint over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
        <time_frame>From Day 1 until the confirmed occurrence of composite renal endpoint (maximum duration: up to 31.5 months)</time_frame>
        <population>Analysis was performed on ITT population. Data for this OM was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Efpeglenatide 4 mg+6 mg</title>
            <description>Included all participants who received either Efpeglenatide 4 mg or 6 mg as SC injection once weekly up to end of treatment (median duration: 19.9 months).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received placebo (matched to Efpeglenatide) as SC injection once weekly up to end of treatment (median duration: 19.8 months).</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of Composite Renal Endpoint: Event Rate Per 100 Participant-years for First Occurrence of Composite Renal Endpoint</title>
          <description>Composite renal endpoint included the following: incident macroalbuminuria (defined as urinary albumin-to-creatinine ratio of greater than (&gt;) 300, as measured in mg of albumin to grams of creatinine, or &gt;33.9, as measured in mg of albumin to millimoles of creatinine), plus an increase in urinary albumin-to-creatinine ratio of at least 30% from baseline, a sustained decrease in estimated glomerular filtration rate (eGFR) of at least 40% for 30 days or more, renal-replacement therapy for 90 days or more, and a sustained eGFR of less than 15 ml per minute per 1.73 m^2 for 30 days or more. Kaplan-Meier curves of the cumulative event rate by treatment groups were used to depict the first occurrence of renal endpoint over time. The event rate per 100 participant-years (calculated by 100*number of participants with events/sum of time at risk (days) over all participants/365.25) measured in terms of number of events per 100 participant-years was reported.</description>
          <population>Analysis was performed on ITT population. Data for this OM was planned to be collected and analyzed for pooled population of participants who received Efpeglenatide (at any dose: 4 mg and 6 mg) as pre-specified in the protocol.</population>
          <units>events per 100 participant-years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2717"/>
                <count group_id="O2" value="1359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" lower_limit="6.9" upper_limit="8.6"/>
                    <measurement group_id="O2" value="11.6" lower_limit="10.2" upper_limit="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Hazard ratio and 95% CI were obtained from a Cox proportional hazards model with region (North America, Latin America, Europe, other), randomization stratum of SGLT2 inhibitor use (current use, potential future use, neither current nor potential future use) and treatment (efpeglenatide 4 mg, efpeglenatide 6 mg, placebo) as fixed effect factor.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Superiority was claimed when the upper bound of the 2-sided 95% CI of hazard ratio was less than 1.</non_inferiority_desc>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Two-sided p-values based on log rank test of hazard ratio.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.675</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.574</ci_lower_limit>
            <ci_upper_limit>0.794</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From time of first injection of investigational medicinal product (IMP) to the last injection of IMP + 30 days (i.e., up to maximum duration of 31.5 months).</time_frame>
      <desc>Reported adverse events (AEs) and deaths were treatment-emergent AEs (TEAEs), which was defined as AEs that developed/worsened/became serious during the TEAE period (defined as time from first injection of IMP to the last injection of IMP + 30 days). Safety population: all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered, analyzed according to treatment actually received.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Participants received placebo (matched to Efpeglenatide) as SC injection once weekly up to end of treatment (median duration: 19.8 months).</description>
        </group>
        <group group_id="E2">
          <title>Efpeglenatide 4 mg</title>
          <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks then 4 mg per week up to end of treatment (median duration: 19.9 months).</description>
        </group>
        <group group_id="E3">
          <title>Efpeglenatide 6 mg</title>
          <description>Participants received Efpeglenatide as SC injection 2 mg per week for 4 weeks, then 4 mg per week for 4 weeks and then 6 mg per week up to end of treatment (median duration: 20 months).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 23.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="1355"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="1360"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="298" subjects_at_risk="1355"/>
                <counts group_id="E2" subjects_affected="312" subjects_at_risk="1360"/>
                <counts group_id="E3" subjects_affected="275" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired Haemophilia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Anaemia Vitamin B12 Deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Autoimmune Haemolytic Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Blood Loss Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypochromic Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Acute Left Ventricular Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="1355"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1360"/>
                <counts group_id="E3" events="17" subjects_affected="17" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" events="29" subjects_affected="23" subjects_at_risk="1355"/>
                <counts group_id="E2" events="23" subjects_affected="20" subjects_at_risk="1360"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arrhythmia Supraventricular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis Coronary Artery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="16" subjects_affected="12" subjects_at_risk="1355"/>
                <counts group_id="E2" events="17" subjects_affected="15" subjects_at_risk="1360"/>
                <counts group_id="E3" events="13" subjects_affected="12" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Atrial Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bundle Branch Block Left</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Acute</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy Acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiovascular Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="1355"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="1360"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Coronary Artery Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Left Ventricular Dysfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Mitral Valve Incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sinus Node Dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sinus Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Tricuspid Valve Incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertrophic Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness Neurosensory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Deafness Unilateral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Meniere's Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vertigo Positional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vestibular Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Thyroid Mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Thyroiditis Chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Eyelid Ptosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Open Angle Glaucoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Retinal Artery Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vitreous Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Incarcerated Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Abdominal Strangulated Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chronic Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Colitis Ischaemic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Gastroparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal Haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastritis Erosive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Sphincter Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Large Intestine Polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Mechanical Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Mesenteric Artery Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Obstructive Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Oesophageal Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Palatal Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pancreatitis Chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Varices Oesophageal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Accidental Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cardiac Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1360"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Impaired Healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1360"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sudden Cardiac Death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sudden Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vascular Stent Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vascular Stent Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune Hepatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholecystitis Chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chronic Hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatic Cirrhosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatic Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hyperplastic Cholecystopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess Soft Tissue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arthritis Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Atypical Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bronchitis Bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Covid-19</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Covid-19 Pneumonia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Campylobacter Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholangitis Infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chronic Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Dermatitis Infected</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Foot Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Gangrene</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Disseminated Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Enterococcal Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Escherichia Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Escherichia Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Escherichia Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Salmonella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Groin Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>H1n1 Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatitis E</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Herpes Zoster Infection Neurological</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Joint Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Klebsiella Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Large Intestine Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Localised Infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Oesophageal Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pilonidal Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="1355"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="1360"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Influenzal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Klebsiella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Mycoplasmal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pulmonary Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pyelonephritis Acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pyelonephritis Chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Cyst Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Salpingitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Scrub Typhus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Skin Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Soft Tissue Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Staphylococcal Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Staphylococcal Sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Suspected Covid-19</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Tuberculosis Gastrointestinal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1360"/>
                <counts group_id="E3" events="5" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection Enterococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vulval Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Wound Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental Overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Anastomotic Complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arterial Bypass Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arterial Bypass Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Brachial Plexus Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Craniocerebral Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Fibula Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Foot Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Heat Exhaustion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Limb Traumatic Amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lower Limb Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lumbar Vertebral Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Meniscus Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Neck Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Patella Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Restenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Periprosthetic Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Postoperative Respiratory Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Procedural Site Reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Radius Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Scapula Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Skin Laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Spinal Compression Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Spinal Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Stomal Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Subdural Haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Tibia Fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Upper Limb Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vascular Graft Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vascular Pseudoaneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Anticoagulation Drug Level Above Therapeutic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Blood Pressure Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Blood Pressure Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Heart Rate Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lipase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Liver Function Test Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Plasminogen Activator Inhibitor Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Troponin Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Weight Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Ketoacidosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Metabolic Decompensation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Food Intolerance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic Hyperosmolar Nonketotic Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lactic Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cervical Spinal Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Groin Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Meniscal Degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Osteochondritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pathological Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Polymyalgia Rheumatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Rotator Cuff Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Spinal Osteoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Spinal Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Of Colon</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Pancreas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Benign Neoplasm Of Scrotum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Benign Neoplasm Of Skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bladder Cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bladder Cancer Recurrent</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bladder Neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bladder Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Breast Cancer Metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chronic Lymphocytic Leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Colorectal Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cutaneous T-Cell Lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diffuse Large B-Cell Lymphoma Stage Iv</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Endometrial Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatocellular Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm Malignant</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Metastases To Liver</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Metastases To Lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Neuroendocrine Tumour Of The Lung Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Lung Cancer Stage Iv</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Oesophageal Adenocarcinoma Stage Iv</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Oesophageal Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Papillary Thyroid Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Recurrent</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Prostatic Adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Rectal Adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Rectal Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Rectosigmoid Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Cell Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Cell Carcinoma Stage Iv</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Oncocytoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Small Cell Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Spinal Cord Neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma Of The Oral Cavity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Thyroid Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Carotid Artery Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Carotid Artery Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="6" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Carotid Sinus Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cervical Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cervicobrachial Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Hyperosmolar Coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Facial Paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hepatic Encephalopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Unconsciousness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ischaemic Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lacunar Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lumbosacral Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Myasthenia Gravis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Senile Dementia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Toxic Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vith Nerve Paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vocal Cord Paresis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Fastener Issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Device Lead Issue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Device Loosening</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Major Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Panic Attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Suicidal Ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1355"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="1360"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chronic Kidney Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Nephropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Nephropathy Toxic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Colic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Renal Impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial Nephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Urinary Bladder Polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Cervical Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Postmenopausal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Prostatic Atrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Bronchitis Chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="7" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lung Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pleurocutaneous Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Sleep Apnoea Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Dermal Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Foot</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="1355"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1360"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Haemorrhage Subcutaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Ischaemic Skin Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arterial Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Diabetic Vascular Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Dry Gangrene</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Essential Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Extremity Necrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypertensive Emergency</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1355"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1360"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Intermittent Claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1355"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="1360"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Circulatory Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1355"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1355"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis Limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1355"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1360"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 23.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="151" subjects_at_risk="1355"/>
                <counts group_id="E2" subjects_affected="348" subjects_at_risk="1360"/>
                <counts group_id="E3" subjects_affected="342" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="69" subjects_affected="64" subjects_at_risk="1355"/>
                <counts group_id="E2" events="139" subjects_affected="116" subjects_at_risk="1360"/>
                <counts group_id="E3" events="153" subjects_affected="117" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="60" subjects_affected="51" subjects_at_risk="1355"/>
                <counts group_id="E2" events="282" subjects_affected="196" subjects_at_risk="1360"/>
                <counts group_id="E3" events="194" subjects_affected="167" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="19" subjects_affected="18" subjects_at_risk="1355"/>
                <counts group_id="E2" events="106" subjects_affected="85" subjects_at_risk="1360"/>
                <counts group_id="E3" events="95" subjects_affected="75" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="1355"/>
                <counts group_id="E2" events="74" subjects_affected="68" subjects_at_risk="1360"/>
                <counts group_id="E3" events="80" subjects_affected="77" subjects_at_risk="1358"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="81" subjects_affected="37" subjects_at_risk="1355"/>
                <counts group_id="E2" events="159" subjects_affected="73" subjects_at_risk="1360"/>
                <counts group_id="E3" events="97" subjects_affected="53" subjects_at_risk="1358"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Sponsor supports publication of clinical trial results but may request that investigators temporarily delay or alter publications in order to protect proprietary information. The Sponsor may also require that the results of multicenter studies be published only in their entirety and not as individual site data.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was terminated early by the Sponsor but not due to any safety concerns.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Trial Transparency Team</name_or_title>
      <organization>Sanofi</organization>
      <phone>800-633-1610 ext 6#</phone>
      <email>Contact-US@sanofi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

